Company · CIK 0001858848 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Tenaya Therapeutics, Inc. · TNYA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 10, 2026 AForm 4 → | Sep 11, 8:10 pm EDT | Faraz AliChief Executive Officer, Director | 122,000 | — | — | 539,782 | — | |
| Sep 10, 2026 AForm 4 → | Sep 11, 8:10 pm EDT | Whittemore TingleyChief Medical Officer | 49,000 | — | — | 263,073 | — | |
| Aug 17, 2026 SForm 4 → | Aug 17, 8:50 pm EDT | Faraz AliChief Executive Officer, Director | 22,232 | $0.7097 | $15,778 | 417,782 | −5.05% | |
| Aug 17, 2026 SForm 4 → | Aug 17, 8:49 pm EDT | Whittemore TingleyChief Medical Officer | 7,424 | $0.7098 | $5,270 | 214,073 | −3.35% |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 10, 2026 AForm 4 → | Sep 11, 8:10 pm EDT | Faraz AliChief Executive Officer, Director | 732,500 | — | — | 732,500 | — | |
| Sep 10, 2026 AForm 4 → | Sep 11, 8:10 pm EDT | Whittemore TingleyChief Medical Officer | 293,000 | — | — | 293,000 | — | |
| Jul 13, 2026 AForm 4 → | Jul 14, 9:00 pm EDT | Eric J HyllengrenChief Financial Officer | 1,650,000 | — | — | 1,650,000 | — |